DEEP TECH WEEK
EXPLORE THE CUTTING EDGE OF:
· AI & Gene Therapy
· Nanotechnology & Drug Delivery
· Diagnostics & Therapeutics
· Longevity & Regenerative Medicine
· Healthcare Innovation
· Venture Capital in a Rapidly Evolving Ecosystem
· State-of-the-Art Biomedical Sciences
CONFIRMED SPEAKERS
Professor of Genetics, Harvard Medical School
Founding Director, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging at Harvard
Co-founder, Sirtris Pharmaceuticals (acquired by GSK for $720M)
Co-founder of MetroBiotech, EdenRoc Sciences, Tally Health, and Life Biosciences
Author of Lifespan: Why We Age and Why We Don't Have To
Biotechnologist, Futurist, and Founder of the Human Genome Project-Write
Chairman, Genome Project-write & Center of Excellence for Engineering Biology
Founder, Humane Genomics & Former Distinguished Researcher in the Bio/Nano Programmable Matter department at Autodesk
Expert in synthetic biology and biomanufacturing innovation
Co-author, The Genesis Machine: Our Quest to Rewrite Life in the Age of Synthetic Biology
Director, Strategic Innovation, Chiesi USA
Biochemist | Scientific Advisor | Mentor | Consultant
MIT's Innovator under 35 (2019)
CEO & Founder, Atomistic Insights
Computational Biophysicist | Chemist
Creating Computational Approaches for Next-Generation Dynamic Protein Modeling
Head of Healthcare Ventures, Lingotto Innovation ($6Bn AUM)
Venture Capitalist | Bioengineer | Medical Engineer
Previously: Medical researcher, scientist and operator with roles at OpenAI, Perkin Elmer, NASA, venture funds and early-stage startups; Applied research in medical robotics, cardiovascular engineering and artificial muscles @ Stanford
General Partner, Terran Applied
Deep Tech & Life Sciences Investor | Former Biologics Manufacturing @ Amgen
Previously: MBA @ Harvard, B.S. ChemE @ MIT
Investment Professional, In-Q-Tel (
Deep Tech, Biotech, AI & Software Investor | National Security
Previously: MBA, JD @ Harvard Business School & Harvard Law School
General Partner, Actual VC
Investing in Science-First Companies to Scale Impact | Forbes 30 Under 30 (Retail & E-commerce, 2021)
Previously: Co-Founder & CEO, ClearMask (Built and Scaled to $40MM ARR before Exit) | Biochemistry & Molecular Biology, Clinical Researcher, MHSc @ Johns Hopkins University
VP, Head of BD & Strategic Alliances, Arbor Biotechnologies; Partner, SummitBio Advisory
Drug Developer | Company Builder | Corporate Strategist | Deal Maker for Advanced Therapies
Previously: Novartis, Editas Medicines
Senior Director, Alliance Management, Nutcracker Therapeutics
Molecular Biologist | Drug Discovery & Design | Personalized Therapeutics
Making medicine more accessible and individualized via novel RNA therapeutic concepts
CEO & Founder, Precigenetics
Live, continuous single-cell biophotonics & multi-omics
Previously: UPenn Computer Science, Computational Bio
CEO & Founder, Ligandal
Inventor (88 patents) | Forbes 30 Under 30 (Healthcare, 2021)
Biomedical Engineer & Drug/Gene Delivery Nanoscientist
Additional Speakers TBA
EVENT SCHEDULE:
BRIEF NETWORKING
12:00 12:25 PM
OPENING REMARKS & A NOTE FROM OUR SPONSOR (ACTUAL.VC)
PRELUDES TO THE FUTURE OF MEDICINE (LIGANDAL)
12:25 - 12:30
FIRESIDE CHAT: BIOMANUFACTURING, BIOSECURITY, AND THE FUTURE OF BIODEFENSE
12:30 - 1 PM
Featuring: Andrew Hessel & Andre Watson (Ligandal)
LIGHTNING TALKS: FROM PREDICTION TO DX TO TX
ATOMISTIC INSIGHTS: PROTEIN DYNAMICS FOR BREAKTHROUGH MEDICINES
1 – 1:10 PM
Featuring: Katie Kuo, PhD (Atomistic Insights)
NON-INVASIVE, CONTINUOUS, SINGLE-CELL MULTI-OMIC DIAGNOSTICS OF THE FUTURE
1:10 – 1:20 PM
Featuring: Paramita Mishra (Precigenetics)
FROM PROMISE TO PATIENT: DELIVERING PERSONALIZED THERAPIES WITH MICROFLUIDIC MANUFACTURING SOLUTIONS
1:20 – 1:30 PM
Featuring: Nicole Fay (Nutcracker Therapeutics)
SPEED NETWORKING & MATCHMAKING
1:30 – 2:00 PM
PANEL: BRIDGING THE BIOTECH VALLEY OF DEATH: HOW VENTURE CAPITAL CAN DRIVE INNOVATION IN UNCERTAIN ECONOMIES
2:00 - 2:30 PM
Featuring: Ileana Pirozzi (Lingotto), Aaron Hsu (Actual VC), Curtis Wu (Terran Applied), James Lim (In-Q-Tel), Andre Watson (Ligandal)
Moderated by Luila Zaimi (The Longevity Adaptation Foundation, Tech M&A @ Deutsche Bank)
THE FUTURE OF PRECISION MEDICINE: HOW PHARMA CAN LEAD IN AN ERA OF CURATIVE THERAPIES
2:30 – 3:00 PM
Featuring: Ester Caffarel-Salvador (Chiesi), Kristine Yu (Arbor Bio)
Moderated by Nicole Fay (Nutcracker Tx)
FIRESIDE CHAT: NANOTECHNOLOGY, PRECISION GENE THERAPY, AND OUR FUTURE OF CURATIVE MEDICINE
3:00 - 3:30 PM
Featuring: Nicole Fay (Nutcracker Tx), Andre Watson (Ligandal)
FEATURED SESSION
FIRESIDE CHAT: THE FUTURE OF LONGEVITY
3:30 - 4:00 PM
Featuring: David Sinclair (Harvard Medical School) & Andre Watson (Ligandal)
This event is part of Deep Tech Week. Create a free profile at deep-tech-week.com/register to help hosts approve your registration and build your schedule for the week.
303 Brooklyn Navy Yard, Brooklyn, NY 11201, USA